Research ArticleOriginal Research
Predictors of Outcome in 216 Subjects With ARDS Treated With Inhaled Epoprostenol
Jose Pacheco, Heather Arnold, Lee Skrupky, Peggy Watts, Scott T Micek and Marin H Kollef
Respiratory Care August 2014, 59 (8) 1178-1185; DOI: https://doi.org/10.4187/respcare.02939
Jose Pacheco
Division of Pulmonary and Critical Care, Washington University School of Medicine, St. Louis, Missouri.
MDHeather Arnold
Department of Pharmacy
PharmDLee Skrupky
Department of Pharmacy
PharmDPeggy Watts
Department of Respiratory Care, Barnes-Jewish Hospital, St. Louis, Missouri.
MSc RRTScott T Micek
St. Louis College of Pharmacy, St. Louis, Missouri.
PharmDMarin H Kollef
Division of Pulmonary and Critical Care, Washington University School of Medicine, St. Louis, Missouri.
MDIn this issue
Respiratory Care
Vol. 59, Issue 8
1 Aug 2014
Predictors of Outcome in 216 Subjects With ARDS Treated With Inhaled Epoprostenol
Jose Pacheco, Heather Arnold, Lee Skrupky, Peggy Watts, Scott T Micek, Marin H Kollef
Respiratory Care Aug 2014, 59 (8) 1178-1185; DOI: 10.4187/respcare.02939